Creation of collaborative relationships or formal agreements with others outside FDA. The collaborations may develop as partnerships, cooperative agreements, or other similar arrangements entered into by a component of FDA and another organization, such as a corporation, educational institution, trade or consumer group, government agency, or foreign government. Leveraging is always cooperative and beneficial to all the parties involved, and is structured to advance FDA's mission to protect and promote the Nation's public health. ... Resources that might be leveraged are numerous, but typical examples would be expertise, equipment, emerging technologies, and databases. FDA, Guidance for FDA Staff, Leveraging Handbook, An agency handbook for effective collaboration, 2003 http://www.fda.gov/oc/leveraging/handbook.html#Agency